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Introduction
The ends of eukaryotic chromosomes
are formed by non-nucleosomal
DNA-protein complexes called
telomeres [1]. Telomeric DNA usual-
ly consists of simple repetitive se-
quences that is GT-rich in the strand
that points 5’-3’ towards the chromo-
some end. The length of telomeric
tracts varies considerably among
species and is typically heteroge-
neous. Human telomeres consist of re-
peats of the sequence TTAGGG/CC-
CTAA with a length of 5,000-15,000
bases.
Telomeres serve as protective caps of
chromosomes and are the substrates
for telomerase, the enzyme which is
required for the complete replication
of chromosomal ends [2]. The very
end of telomeric DNA is single-
stranded and forms a 3’overhang. This
overhang cannot be replicated by the
conventional DNA replication ma-
chinery because the parental CA-rich
strand is recessed and cannot function
as a template [3] (Fig. 1). Telomerase
can solve the end replication problem
because it is a specialized reverse tran-
scriptase that is independent of preex-
isting parental DNA templates. In-
stead, the reverse transcriptase subunit
of telomerase uses a short region of its
associated RNA moiety as a template
for telomeric repeat synthesis (Fig. 2).
In human, telomerase is inactive in
most somatic cells. Thus, telomere
shortening is occurring with succes-
sive cell divisions which is thought to
serve as a counting mechanism that
prevents unlimited proliferation of hu-
man somatic tissues [4, 5]. Converse-
ly, telomerase can be detected in the
germ line, and in immortalized cells
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Fig. 1. The DNA end replication problem. Conventional DNA polymerases need a
template for the synthesis of the daughter strand. Since telomeric DNA contains 3’
terminal extensions the parental molecule (thine lines) cannot provide the template
for the synthesis of this 3’overhang. Upon replication by conventional DNA poly-
merases the daughter molecules (thick line) will lose the 3’overhang on the end
synthesized by leading strand DNA replication.
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and tumors, and such cell populations
maintain telomere length. These obser-
vations have led to a model which pro-
poses that the process of telomere
shortening limits the replicative poten-
tial of most human cell lineages, and
that cancer cells have to overcome this
limit by activating telomerase expres-
sion in the course of tumor progression.
The isolation and identification of
telomerase components has been cru-
cial to the understanding of telomerase
structure and mechanism. In addition,
it has allowed to identify the protein
target which is regulated during cell
immortalization. This is setting the
stage to dissect the role and mecha-
nism of telomerase activation during
cell immortalization and tumorigene-
sis. These recent advances are dis-
cussed here.
Telomerase reverse transcriptase
Telomerase is a ribonucleoprotein par-
ticle (RNP) that uses its stably associ-
ated RNA moiety as the template for
synthesis of telomeric repeats (Fig. 2).
Numerous telomerase RNA’s have
been isolated which vary considerably
in size and sequence. The telomerase
RNAsecondary structure is conserved
among ciliated protozoan [6, 7] but the
structures of the yeast and mammalian
RNA’s are yet to be reported. Func-
tions of this RNA other than provid-
ing the template remain ill defined. 
How is reverse transcription of the
RNA template catalyzed?
To address this question, enzymati-
cally active telomerase was purified
from the ciliated protozoan Euplotes
aediculatus [8]. This organism was
chosen as starting material for the pu-
rification, because it provides a much
richer source for telomerase than for
example human cells. This is due to
the unusual high number of chromo-
somes and therefore telomeres in Eu-
plotes macronuclei [9]. Two protein
subunits, p123 and p43, were identi-
fied.
The gene sequence of the larger sub-
unit, p123, revealed homology to the
yeast EST2 gene [10]. The latter was
one of four genes identified genetical-
ly, in a screen for mutants that have an
ever shorter telomeres (est) phenotype
[11]. The est phenotype is the pheno-
type expected for a telomerase mutant.
It is characterized by continuous
telomere shortening and cessation of
growth or senescence after 50-100
generations, which is caused by in-
complete chromosome end replica-
tion. Significantly, both p123 and
Est2p contained reverse transcriptase
(RT) motifs in their C-terminal part
(Fig. 2B). The N-terminal half of both
polypeptides is very basic. Sequence
similarity is low but detectable
throughout the proteins.
Fig. 2. Telomere DNA synthesis by telomerase. Telomerase consists of essential pro-
tein and RNAsubunits. (A) Asmall region of the RNAserves as a template for telom-
eric DNArepeat synthesis. The chromosome 3’end is annealing to the RNAtemplate.
The telomerase reverse transcriptase subunit than uses the RNA as a template to syn-
thesize a new telomeric repeat at the chromosome 3’terminus. (B) The telomerase re-
verse transcriptase subunits of Euplotes human and yeast contain sequence features
of retroviral RT’s. The aspartates (D) in motifs A and C are crucial for function.
Fig. 3. Model for role of telomere loss and telomerase activation during immor-
talization of human cells (see text for details).
Fig. 2A
Fig. 2B
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The template region of the telomerase
RNAis reverse transcribed giving rise
to telomeric DNA repeats (Fig. 2).
Therefore, Greider and Blackburn
which discovered telomerase more
than 10 years ago [12] had formulat-
ed that telomerase is a reverse tran-
scriptase in a functional sense [13].
The presence of an RT-domain in one
of its subunits suggested that this is al-
so true in a structural sense. As in most
other polymerases, the active site of
reverse transcriptases is present in a
cleft whose structure is often com-
pared to a half-open right hand with
fingers, palm and thumb [14]. Seven
short sequence motifs are usually con-
served among reverse transcriptases
[15]. Most notable are motifs A and C
which contain one and two very criti-
cal aspartate residues, respectively
(Fig. 2B). They are part of the palm sub-
domain and crucial for catalysis, coor-
dinating the active-site Mg2+ ions. 
These telomerase proteins being new
members of the RT family was a
testable hypothesis, since it was
known from the biochemical and
structural analysis of HIV1-RT which
of the conserved residues should be
critical for function. When any of the
three putative active site aspartates
was mutated to alanine in EST2,
telomerase function was abolished
completely (Fig. 2B) [10]. The ob-
served est-phenotype was indistin-
guishable from that observed with a
complete knock-out of the gene. Fur-
thermore, in vitro telomerase activity
was completely absent in extracts de-
rived from strains carrying these point
mutations. On the other hand, muta-
tion of aspartates outside of the iden-
tified motifs had no or less severe ef-
fects. These results provided com-
pelling evidence that p123/Est2p pro-
vides the reverse transcriptase-like ac-
tive site of telomerase. These findings
were confirmed by Counter et al. [16]
who identified the EST2 gene inde-
pendently in an elegant genetic screen.
The Euplotes catalytic subunit gene
led to the identification of the homol-
ogous genes from Schizosaccha-
romyces pombe and human [17], [18].
With examples now identified in pro-
tozoa, fungi and mammals, it appears
that the telomerase reverse transcrip-
ere length during passage from one
generation to the next. In most somat-
ic cells, however, telomerase activity
is low or undetectable [20, 21]. Be-
cause telomeres shrink with age in so-
matic cells, younger individuals have
longer telomeres than old donors [22].
More than 30 years ago, Hayflick and
Moorhead [23] first described the lim-
ited replicative capacity of normal hu-
man fibroblasts in culture as a mani-
festation of cellular senescence. These
cells stop dividing at a senescence
stage called M1 (Fig. 3). Remarkably,
there is a good correlation between the
number of divisions the fibroblasts ex-
ecute before they senesce and their ini-
tial telomere length [22]. Senescent
cells do not divide but are still meta-
bolically active. One of the factors re-
quired for M1 arrest is p53, a protein
that recognizes damaged DNA. It is
unclear what cellular signal triggers
M1 arrest. It could be that p53 recog-
nizes short telomeres. The average
telomere length at M1 is approxi-
mately 5 kb but individual telomeres
may be significantly shorter. M1 ar-
rest can be bypassed by a variety of
agents. Oncogenes such as SV40 large
T, E1A or Myc will allow fibroblasts
to progress beyond M1. Such cells
continue to divide for several genera-
tions before encountering a second
crisis, called M2 (Fig. 3). In contrast
to senescence at M1 most cells die at
M2. While progressing towards M2,
cells continue to lose telomeric DNA.
The average telomere length drops to
2-4 kb and some chromosomes may
have lost telomeric DNA altogether.
Degradation of uncapped chromo-
some ends may eventually affect es-
sential genes. Probably more impor-
tantly, unprotected chromosome ends
form dicentric chromosomes through
end-to-end fusion. The frequency of
dicentric chromosomes rises sharply
in cells approaching M2. 
Nondisjunction of dicentrics results in
chromosome losses many of which are
lethal. Cells that escape from M2 are
immortal, maintain telomere length
and express active telomerase. They
arise at a very low frequency, proba-
bly as a result of mutations in un-
known cellular genes. Some of these
mutations presumably affect the reg-
ulation of telomerase. 
tase subunit is universal among telom-
erases. The other telomerase RT’s
share the sequence features of
p123/Est2p with sizes between 103-
127 kDa, a basic N-terminal region
and an RT-domain more C-terminal
(Fig. 2B). Other conserved character-
istics of the telomerase RT family in-
clude a telomerase-specific motif T
immediately preceding the RT-do-
main and an unusually large distance
between motifs Aand B’. Both of these
regions may be part of the «finger» do-
main which is presumed to interact
with the template RNA. How this may
contribute to the specialized reaction
mechanism of telomerase remains to
be established.
Evolutionary implications
The availability of several telomerase
RT-sequences has stimulated propos-
als regarding the evolutionary rela-
tionship of the telomerase proteins to
other RT’s. Reverse transcriptases can
be divided into two major branches,
those encoded by retroviruses and
long terminal repeat (LTR) retro-
posons and those encoded by non-
LTR retroposons and group II introns
[15]. Telomerase RT’s are more simi-
lar to the non-LTR retroposon branch.
However, they form a novel subfami-
ly with very distinct features. Since
with the exception of telomerase, re-
verse transcriptases are encoded by
parasitic genetic elements, it becomes
an intriguing question if retroposon-
encoded RT’s evolved from telom-
erase or vice versa. It would be amaz-
ing if retroelements, which constitute
more than 30% of the human genome
[19], evolved from telomerase reverse
transcriptase. Alternatively, telom-
erase RT and retroelement-encoded
RT’s may be descendants of a com-
mon ancestor. The first reverse tran-
scriptase may have evolved during the
transition from an RNA world to cur-
rent DNA-based information systems.
Telomerase and cell immortalization 
In man telomerase activity is regulat-
ed during development [4, 5]. It can
be detected in cells of the germ line
where it is required to maintain telom-
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tion make it a prime target for cancer
therapy and thus an important subject
of future research. The reverse tran-
scriptase-like catalytic subunit will be
studied structurally and mechanisti-
cally. A better understanding of the
telomerase mechanism should help to
design and identify drugs that inhibit
this enzyme in human tumors. 
The regulation of human telomerase
reverse transcriptase occurs on the
mRNA level. It will be important to
differentiate a regulation via mRNA
stability, transcription or processing.
The transacting factors that mediate
this regulation are not known. There
identification will be crucial to under-
stand the molecular events that lead to
telomerase activation in tumors.
Finally, as mentioned earlier at least
one other mechanism than telomerase
exists to stabilize telomere length in
immortal human cell lines. This mech-
anism which presumably involves re-
combination between telomeres,
might take over once telomerase is out
of commission. Therefore, if telom-
eres are the Achilles heel of tumors, a
successful anti-cancer therapy might
require inhibition of telomerase and
alternative telomere maintenance
pathways at the same time.
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positive human cell lines (melanoma
LOX IMVI, leukemia U251, lung car-
cinoma NCI H23, colon adenocarci-
noma SW620, breast tumor MCF7,
and kidney carcinoma 293). This in-
dicated that telomerase activity is lim-
ited by the level of hTERT mRNAand
that upregulation of hTERT mRNA
levels may be crucial for telomerase
activation and escape from the M2 cri-
sis. 
Overexpression of telomerase
reverse transcriptase immortalizes
normal human cells
Most compelling evidence for a
causative relationship of telomere
shortening and cellular senescence
was provided most recently [29]. The
identification of the human telom-
erase reverse transcripase subunit
(hTERT) as a regulated component
[17] allowed to test its role during cel-
lular senescence. When hTERT was
overexpressed in primary human cells
(which are normally telomerase-neg-
ative), activity was reconstituted and
telomere length was stabilized [30].
This indicates that of all the compo-
nents that are required for telomerase
activity, only the telomerase reverse
transcriptase subunit hTERT was
missing in the examined cells (retinal
epithelial cells, foreskin fibroblasts,
vascular endothelial cells). When the
replicative potential of the hTERT
transfected and therefore telomerase
positive cells was examined during
proliferation, the result was spectacu-
lar. Whereas the telomerase negative
control cells senesced and stopped di-
viding after 50-60 generations, the
telomerase positive cells continued to
divide vigorously. They had overcome
the limited replicative potential of nor-
mal somatic cells through stabiliza-
tion of their telomere length. Their
karyotype remained normal [29].
Therefore, telomere shortening is
causing cellular senescence. This bar-
rier of unlimited proliferation in nor-
mal human cells appears to provide a
powerful tumor suppressor system.
Future prospects
The causative relationship of telom-
erase activation and cell immortaliza-
Telomerase in human tumors
Support for a critical role of telom-
erase expression in tumorigenesis
came from a comparison of telom-
erase activity levels in normal somat-
ic tissues and in numerous tumors [20,
21]. Telomerase activity is absent in
most somatic cells. An exception to
this are germ line cells which do con-
tain active telomerase. Conversely to
somatic cells, close to 100% of tumors
were found to be telomerase positive
[21]. This indicated that telomerase re-
activation may be an essential step in
carcinogenesis, even though alternative
mechanisms to stabilize telomeres may
exist. Evidence for such mechanisms
came from the work of Bryan et al. [24]
who have investigated telomeres from
in vitro immortalized cell lines. They
found that some lines were telomerase
deficient but maintained telomeres pre-
sumably through a mechanism that in-
volves recombination between differ-
ent telomeres. 
Telomerase reverse transcriptase
mRNA-levels are regulated
The mechanism of telomerase activa-
tion during cell immortalization had
been elusive until recently. Telom-
erase consists of essential protein sub-
units and an RNA moiety. Activity
might be regulated by changes in the
synthesis, the stability or the activity
of any of the components, or by con-
trol of their intracellular localization.
There is no good correlation between
telomerase RNA levels and activity in
different tissues, indicating that
telomerase activity is not controlled
through the level of this RNA [25, 26,
17]. Nor do the levels of mRNA of a
proposed telomerase protein subunit
called TP1 [27] or TLP1 [28] correlate
with activity [17]. 
The human catalytic telomerase pro-
tein subunit gene is called hTERT (hu-
man telomerase reverse transcrip-
tase). hTERT mRNA levels correlate
very well with telomerase activity in
different cells [17, 18]. No hTERT
mRNA could be detected in six dif-
ferent telomerase negative somatic
tissues, whereas it was readily de-
tectable in six immortal, telomerase
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